Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 35, Issue 4, 2015, Pages 519-524

  Wu, Lin ^a   Zhou, Pi Qi ^a   Xie, Ji Wen ^a   Zhu, Rui ^a   Zhou, Sun Chang ^a   Wang, Geng ^a   Wu, Zhong Xu ^b   Hao, Sha ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Xianning Central Hospital   (China)

Author keywords

angiotensin converting enzyme 2; bile duct ligation; liver fibrosis; rein angiotensin system; transforming growth factor 1; Yinchenhao decoction

Indexed keywords

HERBACEOUS AGENT; LOSARTAN; YINCHENHAO;

ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MALE; METABOLISM; PATHOLOGY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LOSARTAN; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84938327473     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-015-1463-9     Document Type: Article

References (22)

1. Munshi MK, Uddin MN, Glaser SS, et al. The role of the renin-angiotensin system in liver fibrosis. Exp Biol Med, 2011,236(5):557–566
2. Zhu R, Yang L, Shen L, et al. ANGII-AT1 receptor pathway involves in the antifibrosis mechanism of β-elemene. J Huazhong Univ Sci Techol Med Sci, 2009,29(2):177–181
3. Yang L, Zhu R, Zhu QJ, et al. Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate cells. Front Med China, 2009,3(1):36–40
4. Warner FJ, Lubel JS, McCaughan GW, et al. Liver fibrosis: a balance of ACEs? Clin Sci, 2007,113(3):109–118
5. Liu C, Sun MY, Wang L, et al. Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats. Chin Med (Chinese), 2008,3:1
6. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct A: new experimental model for cirrhosis in the rat. Br J Exp Pathol, 1984,65(3):305–311
7. Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. Intern Med, 2008,264(3):224–236
8. Bataller R, Schwabe RF, Choi YH, et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. Clin Invest, 2003,112(9):1383–1394
9. Bataller R, Gäbele E, Parsons CJ, et al. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology, 2005,41(5):1046–1055
10. Kanno K, Tazuma S, Chayama K. AT1A-deficient mice show less severe progression of liver fibrosis induced by CCl4. Biochem Biophys Res Commun, 2003,308(1):177–183
11. Osterreicher CH, Taura K, De Minicis S, et al. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology, 2009,50(3):929–938
12. Pereira RM, dos Santos RAS, Teixeira MM, et al. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin(1–7). Hepatology, 2007,46(4):674–681
13. Cao HX, Sui H, Jiang GX, et al. Comparative study on the protective effects of Yinchenhao decoction against liver injury induced by alpha-naphthylisothiocyanate and carbon tetrachloride. Chin J Integr Med (Chinese), 2009,15(3):204–209
14. Komiyama T, Tsukui M, Oshio H. Studies of ‘Inchinko’. I. Capillarisin, a new choleretic substance. Yakugaku Zasshi, 1976,96(7):841–854
15. Guo MZ, Li XS, Xu HR, et al. Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats. Acta Pharmacol Sin, 2002,23(8):739–744
16. Paizis G, Tikellis C, Cooper ME, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut, 2005,54(12):1790–1796
17. Huang, Q, Xie Q, Shi CC, et al. Expression of angiotensin-converting enzyme 2 in CCL4 induced rat liver fibrosis. Int J Mol Med, 2009,23(6):717–723
18. Herath CB, Warner FJ, Lubel JS, et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis. J Hepatol, 2007,47(3):387–395
19. Paizis G, Mark E, Cooper JM, et al. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology, 2002,123(5):1667–1676
20. Zhang W, Miao JF, Li PF, et al. Up-regulation of components of the renin-angiotensin system in liver fibrosis in the rat induced by CCL4. Res Vet Sci, 2013,95(1):54–58
21. Yi ET, Liu RX, Wen Y, et al. Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats. Acta Pharmacol Sin, 2012,33(12):1518–1524
22. Azoulay L, Assimes TL, Yin H, et al. Long-term use of angiotensin receptor blockers and the risk of cancer. PLoS One, 2012,7(12):50893